Key Takeaways

Key players operating in the acellular dermal matrices market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. These companies collectively hold a significant share of the market.

Growing demand for acellular dermal matrices from reconstructive surgery and plastic surgery is a key factor propelling revenue growth of this market. The products help reduce complexity, risk of complications and recovery time in various procedures. Further, increasing incidence of burn injuries globally is also creating the need for improved wound care products.

The acellular dermal matrices market is also witnessing considerable expansion in international markets. Many regional and local players are entering emerging markets of Asia Pacific and Latin America through strategic collaborations with local vendors and hospitals. This is helping increase awareness and accessibility of acellular dermal matrices in these regions.

Market drivers

Rising geriatric population vulnerable to chronic wounds and injuries is a major driver for the Acellular Dermal Matrices Market Size . According to WHO, the number of people aged 65 years and above is projected to rise from 703 million in 2019 to 1.5 billion by 2050. The elderly are more prone to diabetes, vascular diseases and pressure ulcers requiring advanced wound management. Further, greater acceptance of plastic and reconstructive surgeries globally is also fueling the demand for acellular dermal matrices in procedures like breast reconstruction. Growing healthcare expenditure in developing nations boosts the access and uptake of these Advanced Wound Care products as well.

Current geopolitical situations is impacting the growth of Acellular Dermal Matrices Market. Political unrest and conflicts in parts of Asia Pacific and Middle East regions is limiting the availability of raw materials for acellular dermal matrix production. This has led to supply chain disruptions and hike in input costs for manufacturers. Many countries have imposed export restrictions on key ingredients during the ongoing global pandemic further exacerbating supply challenges. However, increasing demand for reconstructive surgeries and burn treatment procedures across major markets is providing stimulus for market expansion. To counter prevailing headwinds, companies need to diversify their supplier base, invest in innovative production technologies and develop cost effective alternative materials. Establishing strategic partnerships with local players in emerging markets and improving accessibility through regulatory approvals and reimbursement coverage can also help sustain future market momentum.

In terms of value, the Acellular Dermal Matrices Market is highly concentrated in North America region currently. The region accounts for over 35% share due to well established reconstructive procedures market and favorable insurance coverage rates in US and Canada. However, growing medical tourism sector in Southeast Asian countries along with increasing disposable incomes is fueling market opportunities in Asia Pacific. China, India and Indonesia are emerging as lucrative pockets and expected to outpace other global regions during the forecast years. Developing healthcare infrastructure, spread of beauty consciousness and rise of medical aesthetics industry are some of the key factors supporting market expansion.

Get more insights on Acellular Dermal Matrices Market